我要投票 Singfiller欣菲聆在玻尿酸行业中的票数:189
· 外 推 电 报 ·
2025-04-04 03:44:39 星期五

【Singfiller欣菲聆是哪个国家的品牌?】

Singfiller欣菲聆是什么牌子?「Singfiller欣菲聆」是 杭州协合医疗用品有限公司 旗下著名品牌。该品牌发源于浙江,由创始人沈晶在2003期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力Singfiller欣菲聆品牌出海!通过在本页面挂载Singfiller欣菲聆品牌的产品链接和联系邮箱,可以提高Singfiller欣菲聆产品曝光!跨境电商爆单神器,目前只要100元/年哦~

2002年,在富阳新登,杭州协合医疗用品有限公司迈出了属于它的第一步。至此,拉开了协合医疗十年发展的大幕。2003年协合医疗迁至富阳高桥工业园区,陆续建起万级净化车间2个、质检中心和研发中心各1个,仓库楼、宿舍楼各一幢,初步实现了由微小企业向中小型企业的过渡。

2011年协合医疗收购海纳医疗(杭州)有限公司,总投资3个亿,开始建设协合医疗下沙新基地,一期已经建成1.7万平方米的标准化厂房,2000平方米的GMP净化车间3个、4000平方米的物流中心、1000平方米的研发及质检中心,可生产各类医疗器械1200余万套,实现产能25亿人民币。截止2013年,协合医疗已拥有下沙、富阳、南昌三个生产基地,杭州、北京、上海、南昌、广州、成都、重庆、福州8个医学营销中心,北京、上海两家医学会展及培训公司,集团员工400余人,年产各类医疗械200多万套,年销售逾5亿人民币,成功实现由创业阶段向快速发展阶段的转型。

协合医疗目前有八大系列产品,每年50余种医疗器械产品销往30个省市,用户达1000余家,部分产品远销往全球40多个国家,如:意大利、俄罗斯、土耳其、法国、巴西、智利、澳大利亚、加拿大。作为以发展新型复合与智能型材料为方向的杭州协合医疗用品有限公司来说,它的坚持,正在备受认可。

协合医疗构建了与国际同步的可吸收生物材料研发平台,在防粘连、止血、微整形材料、组织工程基础材料领域已获得10余项专利,另有多项专利正在申报中。当然,除了产品的研发,严格的质量控制也是企业赖以生存的根本,协合医疗遵循“质量第一、管理优先、建和谐企业、创协合品牌”的质量方针,生产车间采用当代先进的制药工艺生产线和在线监控设备,以确保持续生产出符合国家食品药品监督管理总局(CFDA)法规要求和欧盟MDD指令的第三类医疗器械、药品注射剂产品。越来越多的荣誉,越来越多的新技术,越来越成熟的发展模式,杭州协合医疗用品有限公司正在一步步成为中国可吸收生物材料领域的领军者。

英文翻译:In 2002, in Xindeng, Fuyang, Hangzhou Xiehe Medical Supplies Co., Ltd. took its first step. So far, it has opened the curtain of the development of cooperative medical treatment in the past ten years. In 2003, Xiehe Medical moved to Fuyang Gaoqiao Industrial Park, successively built two 10000 level purification workshops, one quality inspection center and one R & D center, one warehouse building and one dormitory building, initially realizing the transition from small and medium-sized enterprises to small and medium-sized enterprises. In 2011, Xiehe Medical purchased Haina medical (Hangzhou) Co., Ltd. with a total investment of 300 million yuan, and started to build a new base of Xiehe Medical in Xiasha. In phase I, 17000 square meters of standardized factory buildings, 2000 square meters of GMP purification workshops, 4000 square meters of logistics centers and 1000 square meters of R & D and quality inspection centers have been built, which can produce more than 12 million sets of various medical devices and achieve a production capacity of 2.5 billion yuan RMB. As of 2013, Xiehe Medical Co., Ltd. has three production bases in Xiasha, Fuyang and Nanchang, eight medical marketing centers in Hangzhou, Beijing, Shanghai, Nanchang, Guangzhou, Chengdu, Chongqing and Fuzhou, two medical exhibition and training companies in Beijing and Shanghai, with more than 400 employees, an annual production of more than 2 million sets of various medical devices, and an annual sales of more than 500 million yuan. It has successfully realized the transformation from the entrepreneurial stage to the fast stage Transformation of rapid development stage. At present, Xiehe Medical has eight series of products, more than 50 kinds of medical device products are sold to 30 provinces and cities every year, with more than 1000 users. Some products are exported to more than 40 countries around the world, such as Italy, Russia, Turkey, France, Brazil, Chile, Australia and Canada. Hangzhou Xiehe Medical Supplies Co., Ltd., which aims to develop new composite and intelligent materials, is being recognized for its persistence. Synergetic medical has built an internationally synchronized research and development platform for absorbable biomaterials. It has obtained more than 10 patents in the fields of anti adhesion, hemostasis, micro plastic materials and basic materials for tissue engineering, and many other patents are under application. Of course, in addition to product research and development, strict quality control is also the foundation for the survival of enterprises. Xiehe Medical follows the quality policy of "quality first, management first, building a harmonious enterprise and creating Xiehe brand". The production workshop adopts the modern advanced pharmaceutical process production line and on-line monitoring equipment to ensure the continuous production in line with the State Food and Drug Administration (CFDA) Class III medical devices and drug injection products required by regulations and EU MDD directives. With more and more honors, more and more new technologies and more mature development models, Hangzhou Xiehe Medical Supplies Co., Ltd. is becoming the leader in the field of absorbable biomaterials in China step by step.

本文链接: https://www.waitui.com/brand/8f8f64f88.html 联系电话:请联系客服添加

千城特选小程序码

7×24h 快讯

美国2月贸易逆差1227亿美元

美国商务部普查局4月3日发布数据,2月贸易逆差1227亿美元,预估为逆差1235亿美元,前值为逆差1314亿美元。(界面)

2小时前

美股大型科技股盘前普跌,苹果跌超7%

36氪获悉,美股大型科技股盘前普跌,截至发稿,苹果、亚马逊跌超7%,特斯拉、Arm、英伟达跌超6%,Meta跌超5%,谷歌跌超4%,微软、奈飞跌超3%。

2小时前

热门中概股美股盘前普跌,拼多多跌超6%

36氪获悉,热门中概股美股盘前普跌,截至发稿,拼多多跌超6%,京东跌超5%,百度、爱奇艺、阿里巴巴、B站、蔚来跌超3%,理想汽车跌超2%,网易、腾讯音乐、微博跌超1%。

2小时前

高测股份:控股股东张顼拟询价转让4.99%股份

36氪获悉,高测股份公告,公司控股股东张顼计划通过询价转让方式转让27,308,000股,占公司总股本的4.99%,转让原因为自身资金需求。出让方声明所持股份权属清晰,不存在限制或禁止转让情形,且不违反相关减持规定和承诺。本次询价转让的受让方需为具备相应定价能力和风险承受能力的机构投资者。本次询价转让的价格下限不低于发送认购邀请书之日(即2025年4月3日)前20个交易日高测股份股票交易均价的70%。

2小时前

欧盟成员国拟表决对美关税反制措施

欧盟高级官员4月3日表示,欧盟成员国计划9日投票表决针对美方25%钢铝关税的反制措施。欧盟委员会负责贸易和经济安全等事务的委员马罗什·谢夫乔维奇表示,不合理的关税最终只会适得其反,欧盟将以冷静、有步骤且团结一致的方式作出回应。(新华社)

2小时前

本页详细列出关于逆时光 INVERSE TIME的品牌信息,含品牌所属公司介绍,逆时光 INVERSE TIME所处行业的品牌地位及优势。
咨询